Interpreting quantitative cytomegalovirus DNA testing: Understanding the laboratory perspective

Clinical Infectious Diseases

Volumn 54, Issue 12, 2012, Pages 1793-1797

  Kraft, Colleen S ^a   Armstrong, Wendy S ^a   Caliendo, Angela M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CYTOMEGALOVIRUS; DNA SCREENING; HALF LIFE TIME; HUMAN; LABORATORY TEST; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; VIRUS LOAD;

BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DATA INTERPRETATION, STATISTICAL; DNA, VIRAL; HUMANS; TRANSPLANTATION; VIRAL LOAD;

EID: 84861486073     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis212     Document Type: Review

References (18)

1. Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev 2010; 23:550-76.
2. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009; 9:258-68.
3. Roberts TC, Buller RS, Gaudreault-Keener M, et al. Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR. J Clin Microbiol 1997; 35:2224-8. (Pubitemid 27349786)
4. Lisboa LF, Asberg A, Kumar D, et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011; 91:231-6.
5. Richman DD, Whitley RJ, Hayden FG. Clinical virology. 3rd ed. Washington, DC: ASM Press, 2009.
6. Razonable RR, Brown RA, Wilson J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002; 73: 968-73. (Pubitemid 34252365)
7. Abdul-Ali D, Kraft CS, Ingersoll J, Frempong M, Caliendo AM. Cytomegalovirus DNA stability in EDTA anti-coagulated whole blood and plasma samples. J Clin Virol 2011; 52:222-4.
8. Clinical and Laboratory Standards Institute. Quantitative molecular methods for infectious diseases. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2010 . CLSI document MM06-A2.
9. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999; 68:1305-11.
10. Emery VC, Sabin CA, Cope AV, Gor D,Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 2032-6. (Pubitemid 30339241)
11. Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 1996; 34:2695-701. (Pubitemid 26346488)
12. Caliendo AM, Ingersoll J, Fox-Canale AM, et al. Evaluation of realtime PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J Clin Microbiol 2007; 45:1723-7. (Pubitemid 46933898)
13. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002; 186:829-33. (Pubitemid 35013436)
14. Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4):S78-86.
15. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89:779-95.
16. Asberg A, Humar A, Jardine AG, et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant 2009; 9:1205-13.
17. Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000; 181:717-20. (Pubitemid 30131845)
18. Caliendo AM, St George K, Kao SY, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype Amplicor CMV Monitor test in transplant recipients. J Clin Microbiol 2000; 38:2122-7. (Pubitemid 30414326)